Improving TAVI outcomes in intermediate & lower risk patients

PCR London Valves 2015

Learning Objectives

  • To learn about the applicability of TAVI in operable lower-risk groups
  • To understand the limitations of the available data in this cohort
  • To appreciate what is happening in the real world as we gain more long-term data

Presentations available when logged in:

  • Session objectives
  • Can TAVI replace SAVR in low risk patients? Lessons from the randomised trials
  • What is happening in the real world? Lessons from large scale registries
  • How can we improve TAVI outcomes in intermediate & lower risk patients?